ABSTRACT: Introduction: The aim of this study was to determine alterations in axonal excitability in tibial nerve as compared with median nerve axonal excitability in patients with diabetic polyneuropathy. Methods: Six patients with diabetic polyneuropathy and 10 patients with diabetes mellitus without polyneuropathy were enrolled. Results: Compared with diabetic patients without polyneuropathy, the tibial nerve strength-duration time constant was significantly longer and supernormality was lower in those with polyneuropathy. Threshold electrotonus studies showed abnormalities in patients with diabetic polyneuropathy, in which smaller threshold changes from long-depolarizing and hyperpolarizing conditioning, termed "fanning-in," were found. Discussion: This study confirms that axonal excitability is significantly altered in the tibial nerve of patients with diabetic polyneuropathy. Evaluating the axonal excitability of the median and tibial nerves may reveal the presence of length-dependent polyneuropathy at an early stage.
Peripheral neuropathy is characterized by progressive sensory loss, pain, and autonomic dysfunction, which are the most common complications of diabetes. Compared with type 2 diabetic neuropathy, axonal atrophy and axonal loss are more severe in type 1 diabetic neuropathy. 1 Nerve conduction studies have shown that 28%-58% of children with type 1 diabetes mellitus (DM) show signs of sensory diabetic neuropathy, even when they are asymptomatic. [2] [3] [4] [5] Because no curative treatment for diabetic peripheral polyneuropathy (PNP) is available, its early detection and prevention are important.
Evaluation of peripheral nerve function is commonly based on nerve conduction velocity and conduction block. If there is no significant loss of myelinated nerve fibers, routine evaluations may yield normal results. Axonal excitability that is influenced by alteration in voltage-gated ion-channel property and myelin sheath function may be an earlier indicator of the development of peripheral polyneuropathy in patients with type 1 diabetes. 6, 7 We hypothesized that there were alterations in tibial nerve axonal membrane function, even without apparent PNP in type 1 DM. The present study aims to determine early changes in tibial nerve axonal membrane function in type 1 DM before the development of lengthdependent diabetic polyneuropathy.
METHODS
Patients. A total of 284 patients, who were followed up for type 1 DM according to the criteria of the American Diabetes Association were screened in this study. All patients underwent nerve conduction tests. Six had diabetic polyneuropathy and were classified as group 2. Ten randomly selected cases without polyneuropathy were classified as group 1. Group 3 included 14 healthy control subjects. The chosen patients were invited by phone to undergo nerve excitability studies. Arterial blood gas studies were performed on all patients before the study began. The demographic (age, gender), clinical (duration of diabetes, body mass index, glycated hemoglobin [HbA 1c ], and blood glucose levels during the test, mean HbA 1c level, blood glucose for the last 2 years, dose of daily insulin, and arterial blood gas results), and electrophysiological (sural nerve amplitude in microvolts) data of all patients were recorded. None of the patients had any other medical illness that may result in neuropathy. All diabetic patients received multiple daily insulin treatments, which consisted of at least 3 injections per day of rapid-acting insulin. None of the patients were treated with an insulin pump. Written informed consent was obtained from the parents of all participants <18 years of age and from participants >18 years of age, and the study was approved by the local ethics committee.
Clinical Evaluation of Polyneuropathy Using the Clinical
Total Neuropathy Score. Polyneuropathy was evaluated in patients with type 1 DM using the total neuropathy score (TNSc). Using the TNSc, diabetic peripheral neuropathy severity was rated as grade 1 (score 1-7), grade 2 (score 8-14), grade 3 (score 15-21), or grade 4 (score > 21), as described elsewhere. 8 Axonal Excitability. With the aid of the TRONDNF protocol applied by QTRAC software (Institute of Neurology, London, UK), the excitability of the median and tibial motor nerves of all participants was measured. Maximum compound muscle action potentials (CMAPs) were recorded for the abductor pollicis brevis muscle and the abductor hallucis longus muscles using surface electrodes after stimulation of the median nerve at the wrist and the tibial nerve at the ankle, respectively. Each recording of nerve excitability included 5 assessments: the stimulus-response (SR) behavior; the strength-duration time constant (SDTC); threshold electrotonus (TE); the current-threshold (I/V) relationship; and the recovery cycle (RC). The SR curves were generated using 1-ms-duration test current impulses from which the maximal CMAP amplitude was obtained, and a target response of $40% was calculated. The current required to elicit the target response (threshold) was recorded using the quantitative technique. Skin temperature was monitored and maintained at >32 C for each patient.
Statistical Analysis. The THRONDF protocol contains embedded statistical analysis options. We used these statistical tools to compare the patient group with the control group. The Student's t-test was used to compare normal controls and patients without polyneuropathy. A Mann-Whitney U-test was used to compare normal control subjects and patients with polyneuropathy. The analysis of variance test (Kruskal-Wallis) was used to compare normal controls, patients without polyneuropathy, and patients with polyneuropathy. P < 0.05 was considered statistically significant.
RESULTS
Demographics and Clinical Data. The incidence of diabetic polyneuropathy in type 1 DM was 2.8% in our cohort. Patients' clinical characteristics are shown in Table 1 , and all patients, except for those in group 2, had normal sural nerve conduction amplitudes. All patients in groups 1 and 3 had normoactive deep tendon reflexes. Deep tendon reflexes were absent in 2 patients and hypoactive in 3 patients in group 2. Five of the 6 patients in group 2 had paresthesias. In group 2, 4 patients were rated as grade 2 TNSc, and 2 patients were rated as grade 1 TNSc. In group 1, 1 of 10 patients had paresthesias. Only 1 patient was rated as grade 1 TNSc. No significant differences were found in the mean HbA 1c levels over the last 2 years.
Nerve Conduction and Excitability Study Results.
Standard nerve conduction studies were performed for all 16 patients and control subjects. The median nerve sensory and motor characteristics were normal in all patients. Nerve excitability recordings were successfully obtained for all subjects, except for 1 whose record was excluded because of distorted I/V current. The median nerve axonal excitability study did not reveal any striking differences between the patient groups and the control group (Table 2 and Fig. 1 ). Nevertheless, stimulus intensity and stimulus/ response slope, latency, and rheobase were significantly different between groups. There were marked differences in the tibial nerve study between the DM with PNP group compared with the control group and the DM group without PNP, as shown in Table 2 . Moreover, the tibial nerve was more depolarized in patients with diabetic PNP than in control subjects and DM patients without neuropathy. During the recovery cycle, superexcitability, which is a highly sensitive measure of depolarization, 9 demonstrated a prominent reduction in percent threshold change in patients with diabetic PNP compared with that of the control subjects. For threshold electrotonus, reduced percent of threshold change occurred in response to conditioning stimuli in the patients with diabetic PNP. Specifically, depolarizing threshold electrotonus for 90-100 ms and hyperpolarizing threshold electrotonus for 10-20 ms were significantly reduced in patients with diabetic PNP. Consistent with this, the hyperpolarizing I/V slope increased in patients and controls. The "fanning-in" pattern in threshold electrotonus, I/V slope line shift, and decreased superexcitability are consistent with axonal depolarization. 10 There were no significant differences in the measurements of refractoriness between the controls and patients with type 1 DM. SDTC significantly increased in patients with diabetic PNP, whereas there was no significant difference between type 1 DM patients without PNP and control subjects.
Regarding the tibial nerve, type 1 DM patients without PNP showed significant differences compared with controls. The main differences were observed in threshold electrotonus during the hyperpolarizing currents. Moreover, there was a significant increase in threshold electrotonus hyperpolarizing (TEh) (90-100 ms) in patient without PNP. Similar changes were observed in TEh (20-40 ms) and TEh (slope 101-140 ms) ( Table 2 and Fig. 2 ).
DISCUSSION
In this study the excitability of the tibial nerve showed an increase in the SDTC. Moreover, a change was observed in the pattern of threshold electrotonus, with an additional reduction in superexcitability in patients with type 1 DM, even if there were limited axonal function changes in the median nerve. Standard techniques, such as nerve conduction studies, are based on the detection of axonal loss rather than on axonal dysfunction. Therefore, these techniques are unsuitable for early diagnosis and the prevention of disability. 11, 12 Over the last decade, nerve excitability methods have gained interest for their ability to detect neuropathy before axonal loss. These methods provide insight into the axonal membrane potentials, the activity of ion channels, and information regarding pathophysiologic mechanisms that may underlie the development of axonal dysfunction in nerve disorders.
Arnold and colleagues found significant axonal dysfunction in patients with type 1 DM compared with a young control group. 13 In their study, the patients with type 1 DM had a mean age of 26.55 ± 1.54 years and a mean duration of DM of 7.78 ± 1.33 years. However, our patients had been diagnosed earlier and, as a result, the mean duration of DM was longer in the present study. In addition, there was a tendency toward depolarization in patients with diabetic PNP compared with the normal group, but this difference was insignificant, possibly due to the low number of polyneuropathy subjects. The Na + /K + pump maintains a normal axonal electrochemical gradient. 1 Moreover, changes in axonal properties may be due to altered function of axonal voltage-gated ion channels mediated by hyperglycemia in animal models. 14, 15 Insulin and C-peptide are essential for optimal axonal metabolism and function. 16, 17 Kwai et al. showed that axonal function in type 1 DM was maintained within normal limits in patients treated with continuous subcutaneous insulin infusion, but it was not with multiple daily insulin injections, thus highlighting the possible neuroprotective effect of continuous subcutaneous insulin in patients with type 1 DM. 18 Pop et al. showed that insulin resistance in type 1 DM was independently associated with all chronic diabetic complications, such as neuropathy, retinopathy, and nephropathy. 19 The mean blood glucose levels and HbA 1c levels were similar between the diabetic groups in our cohort. A possible explanation for the normal nerve excitability observed in the present study may be the early onset of insulin therapy and more stringent glycemic control. The tibial nerve SDTC was significantly longer in diabetic patients with polyneuropathy than in those without polyneuropathy. Misawa et al. found that the mean SDTC was longer for diabetic patients than normal controls, but the difference was not significant. The good glycemic control subjects had significantly longer SDTC in the tibial nerve than the patient group with poor control. 20 The SDTC is a voltage-dependent property of the nodal membrane that provides an indirect measure of a nodal persistent Na + conductance, so we assume that length-dependent mechanisms also affect nodal Na-dependent properties.
This study showed paresthesias in 60% of patients with diabetic polyneuropathy and in 17% of type 1 DM patients without polyneuropathy. Abnormal deep tendon reflex was observed in all but 1 of the neuropathic patients. Höliner et al. showed that the sensitivity and specificity of the neurologic examination for the diagnosis of diabetic polyneuropathy were 40% and 100%, respectively. 21 Given that the sensitivity and negative predictive values of the neurologic examination are low, all children and adolescents with type 1 DM should be evaluated via routine nerve conduction and axonal excitability methods.
Axonal excitability findings in polyneuropathy subjects are consistent with the depolarization state of the tibial nerve. A depolarization effect may be caused by reduced electrogenic Na-K-adenosine triphosphatase activity. Threshold electrotonus showed more subexcitability during hyperpolarizing currents in polyneuropathy subjects than in those without polyneuropathy. This finding may be related to inwardly rectifying channel dysfunction during the early stage of diabetes, and the hyperglycemic state may affect hyperpolarization-activated cyclic nucleotidgated (HCN) channels before the Na-K pump in the tibial nerve.
In conclusion, detection of polyneuropathy in type 1 DM patients is important because of its effect on prognosis. Diabetic polyneuropathy generally exhibits a length-dependent pattern, making lower limb electrophysiologic studies important. Although axonal excitability evaluations are generally performed for the upper limbs, this study has shown that tibial nerve axonal excitability studies should be performed if normal findings are observed for the median nerve, in order to increase the possibility of early detection of axonal abnormalities in type 1 DM. Evaluating the axonal excitability of the median and tibial nerves has the potential to indicate the lengthdependent polyneuropathic pathologic status at an early stage in symptomatic but electrophysiologically normal patients.
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